Skip to content
40

ass 500 tabletten 100 stück

Skip it

Brand-locked demand (top 5 brands take 100% of clicks) — this niche doesn't clear our bar today.

Market size 46Growth 19Conversion 95Competition 24Returns 100Price range 28Avg price 36Brand share 0Review moat 48Quality gap 20

Returns

Incredible0.0%

return rate — above 6% kills the launch gate

Conversion

Incredible12.5%

search→purchase rate — share of searches ending in a sale

Review moat

Okay1,692.27

avg incumbent reviews — the moat a new listing must climb

Market size

Okay€247K

€247K/yr · 191K searches

Avg price

Okay€10.33

avg listing price — sweet spot $15–$100

Price range

Okay€6.87–€18.15

cheapest to priciest tracked listing — scored on the share inside $15–$100

Competition

Bad72%

top-5 click share — a locked-up shelf

Quality gap

Bad4.7★

avg incumbent rating — lower means beatable quality

Growth

Bad-12.3%

90-day search growth — must beat 0% to launch

Brand share

Bad100%

top-5 brand share — brand-locked demand

Competition

The top 5 products capture 72% of clicks — a locked-up shelf that new listings rarely crack.

Brands

5 falling

Sellers

24

Top-5 brand share

100%

Open market

0%

  • Aspirin67%
  • Bayer11%
  • ratiopharm10%
  • apo-discounter.de6%
  • 1A PHARMA6%

Product shelf

Each bubble is one product — market share against review moat; bubble size tracks estimated sales, color grades how beatable the incumbent looks.

0%10%€25K20%€49K30%€74K40%€99K101001K10K Reviews — right = deep review moat Market share (90d) ≈ est. sales
Beatable (≤4.3★) Contested Strong incumbent (>4.7★)

All 11 tracked products in this niche — three views at once, no toggling.

Reviews

What buyers praise and complain about, mined from review topics.

Top return reasons

Dosierung50%
beworben Vs Tatsächliches Produkt50%